ISPOR - HTA124 Payer Perceptions of Supportive Evidence in the Estimation of Long-Term Durability for Gene Therapies in Major European Markets

Full Text

HTA124 Payer Perceptions of Supportive Evidence in the Estimation of Long-Term Durability for Gene Therapies in Major European Markets

Abstract

Authors

M Crisci J Sanseau J Haberl S Morrison

Back to Volume 27, Supplemental Issue 12S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now